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Abstract CRISPR/Cas9 system has been used widely in an-
imals and plants to direct mutagenesis. To date, no such meth-
od exists for fish somatic cell lines. We describe an efficient
procedure for genome editing in the Chinook salmon
Oncorhynchus tshawytscha CHSE. This cell line was geneti-
cally modified to firstly overexpress a monomeric form of
EGFP (cell line CHSE-E Geneticin resistant) and additionally
to overexpress nCas9n, a nuclear version of Cas9 (cell line
CHSE-EC, Hygromycin and Geneticin resistant). A pre-
validated sgRNAwas produced in vitro and used to transfect
CHSE-EC cells. The EGFP gene was disrupted in 34.6 % of
cells, as estimated by FACS and microscopy. The targeted
locus was characterised by PCR amplification, cloning and
sequencing of PCR products; inactivation of the EGFP gene
by deletions in the expected site was validated in 25 % of
clones. This method opens perspectives for functional geno-
mic studies compatible with high-throughput screening.
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Abbreviations
CRISPR Clustered regularly interspaced short palindrom-
ic repeat
Cas CRISPR-associated
PAM Protospacer adjacent motif
qPCR Quantitative polymerase chain reaction
CHSE CHinook salmon embryo





The CRISPR/Cas (clustered regularly interspaced palindrom-
ic repeats/CRISPR-associated) system was initially discov-
ered in the genome of Escherichia coli (Ishino et al. 1987),
and later found in about 40 % of bacteria, and a great majority
of Archae (Horvath and Barrangou 2010). It functions as a
bacterial protection systemwith memory directed against bac-
teriophages whereby double-stranded DNA molecules from
viral origin are cleaved (Horvath and Barrangou 2010). The
mechanism was characterised in Streptococcus, where the en-
donuclease Cas9 binds two RNA molecules, a CRISPR
(cr)RNA targeting a complementary sequence on the viral
genome, and a trans-activating (tra)crRNA acting as a
transactivator (Jinek et al. 2012; Deltcheva et al. 2011). The
isolation and characterisation of the Cas9 protein enabled to
establish a method for genome editing in a wide range of
organisms generating knockout models very efficiently and
very quickly using small Bguide RNA molecules^ sgRNA in
which cr and tracrRNA are fused (Ran et al. 2013; Sander and
Joung 2014; Hsu et al. 2014). This system has been used in a
number of species including fish, to generate lines of site-
directed mutated animals by egg manipulation: zebrafish
(Hruscha et al. 2013; Hwang et al. 2013; Kimura et al. 2014;
Jao et al. 2013; Irion et al. 2014), Atlantic salmon (Edvardsen
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et al. 2014) or tilapia (Li et al. 2014). However, while
CRISPR/Cas9-based methods have been used for genome
editing in mammalian cell lines, to date, no such a system
had been set up in somatic fish cell lines. This communication
presents an efficient method to generate CRISPR/Cas9 knock-
out in the Chinook salmon Oncorhynchus tshawytscha cell
line, CHSE-214.
Material and Methods
The CHSE-214 (referred as CHSE) cell line (ATCC
CRL1681) was genetically engineered to overexpress a mo-
nomeric, cytosolic form of EGFP (mEGFP) using a method
described previously by Lester et al. (2012) with the plasmid
pmEGFP-N1 kindly provided by Prof. Reich (Chen and Reich
2010), conferring resistance to Geneticin G418. The resulting
cell line, named CHSE-E, was maintained in CHSE culture
medium supplemented with 500 μg/ml G418 (ThermoFisher
Scientific).
A eukaryotic expression plasmid encoding the protein
nCas9n, a nuclear version of the Cas9 from Streptococcus
pyogenes, was constructed by subcloning the HindIII/XbaI
fragment of pCS2-nCas9n (a gift from Wenbiao Chen,
Addgene plasmid # 47929) (Jao et al. 2013; Edvardsen et al.
2014) into pcDNA3.1-Hyg (ThermoFisher Scientific) to ob-
tain the plasmid pcDNA3.1-Hyg-nCas9n. The CHSE-E cell
line (passage 30) was genetically engineered using this plas-
mid as described previously by Lester et al. (2012) to generate
the CHSE-EC cell line, and cultivated in CHSE-E medium
supplemented with 30 μg/ml Hygromycin B (ThermoFisher
Scientific). The nCas9n transcript levels were measured by
qPCR as described previously by Collet and Lester (2011)
using primers nCas9nF 5′-CGACGCAAATCTGGATAAGG-3′
and nCas9nR 5′-GATCAGTGTAGCGTCCAGCA-3′.
Pre-validated sgRNA targeting EGFP was produced as de-
scribed previously by Hwang et al. (2013) using DR274-
eGFP (a gift from Filippo Del Bene; Addgene plasmid
#61051; Auer et al. 2014). The targeted site for EGFP was
GGCGAGGGCGATGCCACCTA starting at position 100
(within the ORF and relative to START codon) followed by
the Protospacer adjacent motif (PAM) CGG. The sgRNAwas
produced in vitro using the Promega T7 transcription kit, pu-
rified using TRIzol (ThermoFisher Scientific), treated with
RNAse-free DNase (ThermoFisher Scientific) and quantified
by spectrometry (Nanodrop, Labtech International). CHSE-
EC cells (passage 5) were transfected with sgRNA using the
same conditions as established for plasmids for CHSE cells
and described previously by Collet and Lester (2011), i.e.,
500 ng sgRNAwas used per 10 μl cell suspension at approx.
107 cells/ml. Twenty four (24) hours after passage, an analysis
by FACS was performed alongside the parental CHSE and
CHSE-E cell lines, acting as negative and positive controls
for EGFP. Cel ls were trypsined with 1x trypsin
(ThermoFisher Scientif ic) , washed in 1x HSBSS
(ThermoFisher Scientific), centrifuged for 10 min at 400g,
resuspended in IF Media (PBS supplemented with 2 % FCS
and 0.05 % sodium azide (Sigma-Aldrich)) and analysed
using an Accuri®C6 analyser (BD Biosciences). A total of
50,000 events were collected from the live cell gate and data
analysed using CFlow®Plus software.
From the same population of sgRNA-transfected CHSE-
EC cells analysed by FACS, genomic DNAwas purified using
the DNeasy kit (Qiagen). A fragment containing the 20 nucle-
otide EGFP genomic target was amplified using the primers
mEGFP-F 5′-ACGGCCACAAGTTCAGC-3′ and mEGFP-R
5′CGTCGCCGATGGGGGTGTTCT-3′. PCR was carried out
using the FastStart High Fidelity PCR system (Roche) accord-
ing to the manufacturer’s instructions. The PCR product was
cloned using pGEM-T easy (Promega) according to the man-
ufacturer’s instructions and sequenced (VWR sequencing ser-
vices). Sequencher software (Gene Codes Corporation) was
used to analyse chromatogram and detect indel mutations.
Results
CHSE-E displayed an intense fluorescence under an EVOSfl
inverted fluorescent microscope (Advanced Microscopy
Group) after more than 30 passages (Fig. 1a). The cloning
process used in CHSE and CHSE-E was previously described
byCollet and Lester (2011) and consisted in a small number of
clonal cells (<500 cells) isolated, subcultured in a 25-cm2
flask and passaged at least 4 times in 75-cm2 flasks.
Therefore, it is reasonable to assume that the quantity of the
residual plasmid had become insignificant relative to the inte-
grated transgene. PCR analysis of cDNA made from RNA
purified from the CHSE-EC clonal cell line showed a strong
expression of nCas9n when compared to mock cDNA pro-
duced by omitting reverse transcriptase (data not shown). In
addition, the 192 nucleotide Cas9 fragment could be amplified
by PCR directly from genomic DNA purified from CHSE-
EC, indicating that at least one copy of the plasmid should
be integrated in the genome of the CHSE-EC cell line (data
not shown).
Following transfection, a proportion of cells on the mono-
layer had lost its fluorescence as assessed by simple micros-
copy observation (Fig. 1a, b). During FACS analysis, the vi-
able cells were gated (region P6, Fig. 1c) and analysed for
their fluorescence. Cell populations from the regions 4 and 5
were composed mainly of dead cells. The sgRNA-transfected
CHSE-EC cells were composed of two populations, with
levels of fluorescence corresponding to EGFP− CHSE
(35 %) and EGFP+ CHSE-E (65 %), respectively (Fig. 1c,
bottom panel). These results suggested that transfection with
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sgRNA resulted in a decreased level of EGFP in 35 % of the
CHSE-EC cells.
The genomic region around the targeted locus was se-
quenced from a PCR product obtained from genomic DNA
purified from the sgRNA-transfected CHSE-EC cells. Out of
24 clones sequenced, 18 were showing 5 different mutated
patterns and 6 were wild type (Fig. 2).
Discussion
To our knowledge, this is the first description of a successful
method to generate KO in somatic cell lines from non-
mammalian vertebrates. We have genetically engineered the
cell line CHSE-EC expressing EGFP and nCas9n using
CRISPR/Cas 9-based genome editing to knockout the inte-
grated EGFP gene. An early step of verification by PCR and
sequencing can detect and estimate the frequency of deletion
mutants, which can be followed by isolation of clonal cell
lines by flow sorting or low-density seeding. It allows fast
and efficient knockout of genome targets in a single round
of transfection with a specific sgRNA easily produced in vitro.
One clone (clone 6, Fig. 2) showed deletions in two sites
whereas Auer et al. (2014) did not detect any such events at
Fig. 1 Fluorescent monolayer of
the CHSE-EC (passage 5) cell
line before (a) and after (b)
transfection with the sgRNA
targeting the EGFP locus. Bright
field and fluorescence images
have been overlaid in B in order
to visualise non-fluorescent cells.
Intensities of each channel have
been adjusted for maximum
visibility. FACS analysis of
CHSE, CHSE-EC before and
after sgRNA transfection (c): left
panel: flow cytometry gating
scheme (FSC-A, x-axis; SSC-A,
y-axis). Populations P4, P5 and
P6 were distinguished. Right
panel: GFP fluorescence intensity
of the P6 gated population
(FL1-A, x-axis), number of cells
(y-axis) and % of gated
fluorescent cells are indicated
Fig. 2 Indel mutations isolated from genomic DNA purified from the
sgRNA-transfected CHSE-EC cells. Sequence alignment in the sgRNA
target (a) and corresponding chromatograms (b)
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the targeted site when editing the genome in zebrafish embry-
os using the same sgRNA. Although the number of clones
analysed is low, this may reflect slight differences in the way
Cas9 operates between salmon and zebrafish cells, possibly
related to different temperatures (23 °C in the present study,
28 °C for zebrafish). The efficiency measured in the present
study (approx. 35 %) is related to the editing of a single hap-
lotype. Efficient knockout of a given endogenous gene would
require the mutation of the target on two haplotypes which
may be performed at lower efficiency with the present meth-
od. However, many factors can influence the knockout effi-
ciency, and it is likely that the delivery of sgRNA to the nu-
cleus of CHSE-EC is one of the main limiting factors rather
than the number of haplotypes to target, in which case the
efficiency of a double disruption should be comparable to
the one assessed here for EGFP. As a matter of fact, the
CRISPR/Cas9 system has been used efficiently to target sev-
eral alleles in hexaploid species such as bread wheat (Wang
et al. 2014) or other multiple target species (see for review
Kim and Kim 2014). In consequence, we are confident that
the frequency of knockout provided by this method on two
haplotypes would be higher than a few per cent.
Non-fluorescent CHSE-C and ASK-C (Atlantic Salmon
Kidney, Salmo salar) cell lines are currently being engineered
for genome editing in both salmon species to provide material
for high-efficiency CRISPR/Cas9 genome editing. This meth-
od has the potential to be applied to any endogenous target and
to provide a cost-effective functional genomic tool in fish
compatible with high-throughput screening.
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